MSD Animal Health UK is proud to be donating over 30 000 microchips, including HomeAgain® microchips, to animal welfare charities the RSPCA, Hearing Dogs, Redwings, Bransby Horse Rescue, and the Donkey Sanctuary, as part of its commitment to improving animal health. The HomeAgain microchip allows dog, cat, and horse owners to update their contact information […]
MILTON KEYNES, U.K., 7th March 2023 – The latest round of farm equipment and technology grants has made herd monitoring systems such as SenseHub® and Dataflow II from MSD Animal Health UK Limited (a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) more affordable in England. The option to use SenseHub and […]
MILTON KEYNES, U.K., Feb. 8, 2023 – MSD Animal Health UK Limited, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), is pleased to announce that the British Trout Association (BTA) has given Dr Chris Gould, Associate Director – Global Aquaculture Technical Service, Cold Water Biopharma, the Peter Jones Award, which honours individuals […]
MILTON KEYNES, U.K., May 25, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today welcomed the National Office of Animal Health (NOAH) Livestock Vaccination Guideline for the dairy, beef and sheep sectors. Published on Tuesday, 24 May 2022, the report advocates a progressive livestock vaccination strategy across […]
Proprietary Technology Enhances Health and Environmental Monitoring Solutions for Poultry Producers Milton Keynes, UK 25 February 2021 – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK) today announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders. Poultry Sense Ltd. is […]
Milton Keynes, UK, 9 February 2021 – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today received two prestigious awards from Animal Pharm, the most widely read publication reporting on the animal health industry. Richard DeLuca was recognized with the 2020 Visionary/CEO award and NOBILIS® SALENVAC® ETC was awarded […]
MILTON KEYNES, November 10, 2020 – Following an extensive review of its operations, effective 1 January 2021 MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA., will be changing the way it distributes its products in Great Britain, opting to engage more directly with customers. The move is being made so […]
With 2020 on the way to being the hottest year on record leading scientists are warning that our pets are at increased risk from parasites including ticks and fleas.
MSD Animal Health announced the Protect Our Future Too initiative (#Protectourfuturetoo) to raise awareness of the risks to our household pets caused by seasonal changes, such as warmer months in autumn and winter as well as higher temperatures in general.
MSD Animal Health today announced the completion of its previously announced acquisition of the worldwide rights to VECOXAN® (diclazuril), an oral suspension for the prevention and treatment of coccidiosis in calves and lambs, from Elanco Animal Health.